ACS Combinatorial Science · 2017 · 49 citations · 33 references
Life SciencesMedicinal ChemistryMolecular BiologyChromatin BiologyCombinatorial ChemistryEpigeneticsChromatinEnzyme FunctionLigand BindingPeptidomimetic DesignPolycomb RegulationProtein DesignAllosteric ActivationAllosteric Activation MechanismsAllosteric Inhibition MechanismsEed FunctionEpigenetic Gene RepressionPolycomb Repressive Complex 2Polycomb-mediated Gene RepressionPolycomb-mediated Repression
The function of EED within polycomb repressive complex 2 (PRC2) is mediated by a complex network of protein–protein interactions. Allosteric activation of PRC2 by binding of methylated proteins to the embryonic ectoderm development (EED) aromatic cage is essential for full catalytic activity, but details of this regulation are not fully understood. EED’s recognition of the product of PRC2 activity, histone H3 lysine 27 trimethylation (H3K27me3), stimulates PRC2 methyltransferase activity at adjacent nucleosomes leading to H3K27me3 propagation and, ultimately, gene repression. By coupling combinatorial chemistry and structure-based design, we optimized a low-affinity methylated jumonji, AT-rich interactive domain 2 (Jarid2) peptide to a smaller, more potent peptidomimetic ligand ( K d = 1.14 ± 0.14 μM) of the aromatic cage of EED. Our strategy illustrates the effectiveness of applying combinatorial chemistry to achieve both ligand potency and property optimization. Furthermore, the resulting ligands, UNC5114 and UNC5115, demonstrate that targeted disruption of EED’s reader function can lead to allosteric inhibition of PRC2 catalytic activity.
33
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Ru Cao, Liangjun Wang, Hengbin Wang et al. · Science · 2002 · 3.8K citations
The polycomb group protein EZH2 is involved in progression of prostate cancer
Sooryanarayana Varambally, Saravana M. Dhanasekaran, Ming Zhou et al. · Nature · 2002 · 2.7K citations · Full text
A new type of synthetic peptide library for identifying ligand-binding activity
Kit S. Lam, Sydney E. Salmon, Evan M. Hersh et al. · Nature · 1991 · 1.8K citations
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe, Heidi M. Ott, Gopinath Ganji et al. · Nature · 2012 · 1.8K citations